Rena Buckstein
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 99
- Acute Myeloid Leukemia Research 85
- Multiple Myeloma Research and Treatments 17
- Genetics 80
- Chronic Lymphocytic Leukemia Research 35
- Hemoglobinopathies and Related Disorders 31
- Myeloproliferative Neoplasms: Diagnosis and Treatment 23
- Co-authors
- Richard A. WellsMichael J. RauhHagop M. KantarjianMark D. MindenKevin ImrieMichael CrumpBrooke SnetsingerMatthew C. Cheung
- Journals
- Blood (66 papers)Leukemia Research (16 papers)Journal of Clinical Oncology (14 papers)British Journal of Haematology (9 papers)Annals of Hematology (6 papers)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Rena Buckstein
181 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Hematology 2.5k
- Genetics 1.6k
- Pathology and Forensic Medicine 1.4k
- Oncology 1.5k
- Immunology 762
Countries citing papers authored by Rena Buckstein
This map shows the geographic impact of Rena Buckstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rena Buckstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rena Buckstein more than expected).
Fields of papers citing papers by Rena Buckstein
This network shows the impact of papers produced by Rena Buckstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rena Buckstein. The network helps show where Rena Buckstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Rena Buckstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2017 | 6 | |
| 8 | 2017 | 15 | |
| 9 | 2017 | 15 | |
| 10 | 2016 | 2 | |
| 11 | 2015 | 25 | |
| 12 | 2014 | 17 | |
| 13 | Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia Hit paper breakdown → | 2012 | 818 |
| 14 | 2012 | 42 | |
| 15 | 2012 | 17 | |
| 16 | 2011 | 17 | |
| 17 | 2011 | 13 | |
| 18 | 2007 | 3 | |
| 19 | 2003 | 19 | |
| 20 | 2002 | 46 |
About Rena Buckstein
Rena Buckstein is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Geriatrics and Gerontology, having authored 191 papers that have together received 5.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (85 papers), Lymphoma Diagnosis and Treatment (70 papers), Chronic Lymphocytic Leukemia Research (35 papers), Hemoglobinopathies and Related Disorders (31 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Neutropenia and Cancer Infections (21 papers), Viral-associated cancers and disorders (20 papers) and Multiple Myeloma Research and Treatments (17 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (1.6k citations), Pathology and Forensic Medicine (1.4k citations), Oncology (1.5k citations) and Immunology (762 citations). Rena Buckstein has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Richard A. Wells, Michael J. Rauh, Hagop M. Kantarjian, Mark D. Minden, Richard A. Wells, Kevin Imrie, Michael Crump, Brooke Snetsinger, Matthew C. Cheung and David Spaner. Their work appears in journals such as Blood, Leukemia Research, Journal of Clinical Oncology, British Journal of Haematology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.